financetom
Business
financetom
/
Business
/
--Blackstone Mortgage Trust Maintains Quarterly Dividend at $0.62 Per Share; Payable July 15 to Shareholders as of June 28
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Blackstone Mortgage Trust Maintains Quarterly Dividend at $0.62 Per Share; Payable July 15 to Shareholders as of June 28
Jun 14, 2024 1:44 PM

04:22 PM EDT, 06/14/2024 (MT Newswires) --

Price: 17.60, Change: +0.17, Percent Change: +0.99

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US retailers aim to cash in on Cyber Monday with steep online discounts
US retailers aim to cash in on Cyber Monday with steep online discounts
Dec 2, 2024
(Reuters) - After lackluster spending at U.S. stores on a deals-heavy Black Friday, retailers will be pulling out all the stops with steep promotions on their websites and apps to entice people to buy holiday gifts and other merchandise after the long Thanksgiving weekend. Retailers have been coaxing cautious U.S. shoppers on Cyber Monday with push notifications, emails and other...
TD Reviews Last Week's Economic, Policy Events in Canada
TD Reviews Last Week's Economic, Policy Events in Canada
Dec 2, 2024
08:35 AM EST, 12/02/2024 (MT Newswires) -- Last week United States President-elect Donald Trump surprised markets and analysts with the threat of a 25% across-the-board tariff on Canadian and Mexican-made goods, which would be implemented as soon as the incoming administration takes office in January, noted TD. The clearest impact from this announcement was seen on the Canadian dollar (CAD...
Cytokinetics Says US FDA Accepts New Drug Application for Aficamten to Treat Obstructive Hypertrophic Cardiomyopathy
Cytokinetics Says US FDA Accepts New Drug Application for Aficamten to Treat Obstructive Hypertrophic Cardiomyopathy
Dec 2, 2024
08:36 AM EST, 12/02/2024 (MT Newswires) -- Cytokinetics ( CYTK ) said Monday it has received acceptance for its new drug application of cardiac myosin inhibitor aficamten from the US Food and Drug Administration to treat obstructive hypertrophic cardiomyopathy. The decision was based on Cytokinetics' ( CYTK ) pivotal phase 3 clinical study for 24 weeks of aficamten that demonstrated...
Intel CEO Pat Gelsinger retires from struggling chipmaker
Intel CEO Pat Gelsinger retires from struggling chipmaker
Dec 2, 2024
(Reuters) -Intel ( INTC ) CEO Pat Gelsinger has retired, the company said on Monday, following a tumultuous period for the chip pioneer that has struggled to keep up in the AI era with players like Nvidia dominating the market. The company named Chief Financial Officer David Zinsner and senior executive Michelle Johnston Holthaus as interim co-chief executive officers while...
Copyright 2023-2026 - www.financetom.com All Rights Reserved